Cargando…
Moving forward in the treatment of cholangiocarcinoma
Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatment of cholangiocarcinoma (CCA) are still unsatisfactory. In fact, survival after 5 years is expected in less than one fourth of patients diagnosed with this disease. Rare incidence, late appearance of sy...
Autores principales: | Manzia, Tommaso M, Parente, Alessandro, Lenci, Ilaria, Sensi, Bruno, Milana, Martina, Gazia, Carlo, Signorello, Alessandro, Angelico, Roberta, Grassi, Giuseppe, Tisone, Giuseppe, Baiocchi, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713313/ https://www.ncbi.nlm.nih.gov/pubmed/35070034 http://dx.doi.org/10.4251/wjgo.v13.i12.1939 |
Ejemplares similares
-
Chronic rejection after liver transplantation: Opening the Pandora’s box
por: Angelico, Roberta, et al.
Publicado: (2021) -
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger?
por: Lenci, Ilaria, et al.
Publicado: (2020) -
Vascular Involvements in Cholangiocarcinoma: Tips and Tricks
por: Angelico, Roberta, et al.
Publicado: (2021) -
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature
por: Manzia, Tommaso Maria, et al.
Publicado: (2019) -
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table
por: Grassi, Giuseppe, et al.
Publicado: (2021)